Clinical trial
Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
NCT02019342 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 30, 2011
- Completion date
- January 31, 2014
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
death, myocardial infarction, postoperative complications, renal failure, stroke